GALT icon

Galectin Therapeutics
GALT

Overview Fund Activity

79 hedge funds and large institutions have $26.8M invested in Galectin Therapeutics in 2024 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 4 closing their positions.

Holders
79
Holders Change
+6
Holders Change %
+8.22%
% of All Funds
1.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
21
Reduced
18
Closed
4
Calls
$3.89M
Puts
$5.46M
Net Calls
-$1.57M
Net Calls Change
-$3.8M

Top Buyers

1
SIA
1
Soltis Investment Advisors
Utah
$387K
2
Northern Trust
2
Northern Trust
Illinois
$644K
3
Osaic Holdings
3
Osaic Holdings
Arizona
$3.25M
4
BlackRock
4
BlackRock
New York
$4.42M
5
Kovitz Investment Group Partners
5
Kovitz Investment Group Partners
Illinois
$117K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$224K
2
Squarepoint
2
Squarepoint
New York
$75.4K
3
Man Group
3
Man Group
United Kingdom
$34.8K
4
GWM
4
Geneos Wealth Management
Colorado
$971K
5
New York State Common Retirement Fund
5
New York State Common Retirement Fund
New York
$35K
Name Holding Trade Value Shares
Change 		Shares
Change %
Fidelity Investments
76
Fidelity Investments
Massachusetts
$501 +$501 +182 New
SIC
77
Salem Investment Counselors
North Carolina
$460 – – –
SCM
78
Sterling Capital Management
North Carolina
$105 +$105 +38 New
AGM
79
Alpine Global Management
New York
– -$44.2K -19,555 Closed
Connor, Clark & Lunn Investment Management (CC&L)
80
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$37.5K -16,611 Closed
VF
81
Virtu Financial
New York
– -$25K -11,233 Closed
Citadel Advisors
82
Citadel Advisors
Florida
– -$1.86K -823 Closed
1 2 3
4